422 related articles for article (PubMed ID: 17543082)
1. Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists.
Kerkhof M; van Dekken H; Steyerberg EW; Meijer GA; Mulder AH; de Bruïne A; Driessen A; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD;
Histopathology; 2007 Jun; 50(7):920-7. PubMed ID: 17543082
[TBL] [Abstract][Full Text] [Related]
2. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression.
Skacel M; Petras RE; Gramlich TL; Sigel JE; Richter JE; Goldblum JR
Am J Gastroenterol; 2000 Dec; 95(12):3383-7. PubMed ID: 11151865
[TBL] [Abstract][Full Text] [Related]
3. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
[TBL] [Abstract][Full Text] [Related]
4. Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies.
Downs-Kelly E; Mendelin JE; Bennett AE; Castilla E; Henricks WH; Schoenfield L; Skacel M; Yerian L; Rice TW; Rybicki LA; Bronner MP; Goldblum JR
Am J Gastroenterol; 2008 Sep; 103(9):2333-40; quiz 2341. PubMed ID: 18671819
[TBL] [Abstract][Full Text] [Related]
5. Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.
Singh R; Anagnostopoulos GK; Yao K; Karageorgiou H; Fortun PJ; Shonde A; Garsed K; Kaye PV; Hawkey CJ; Ragunath K
Endoscopy; 2008 Jun; 40(6):457-63. PubMed ID: 18459090
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.
Montgomery E; Bronner MP; Goldblum JR; Greenson JK; Haber MM; Hart J; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Toledano AY; Shyr Y; Washington K
Hum Pathol; 2001 Apr; 32(4):368-78. PubMed ID: 11331953
[TBL] [Abstract][Full Text] [Related]
7. Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel.
Duits LC; Phoa KN; Curvers WL; Ten Kate FJ; Meijer GA; Seldenrijk CA; Offerhaus GJ; Visser M; Meijer SL; Krishnadath KK; Tijssen JG; Mallant-Hent RC; Bergman JJ
Gut; 2015 May; 64(5):700-6. PubMed ID: 25034523
[TBL] [Abstract][Full Text] [Related]
8. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus.
Wani S; Falk GW; Post J; Yerian L; Hall M; Wang A; Gupta N; Gaddam S; Singh M; Singh V; Chuang KY; Boolchand V; Gavini H; Kuczynski J; Sud P; Bansal A; Rastogi A; Mathur SC; Young P; Cash B; Goldblum J; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2011 Oct; 141(4):1179-86, 1186.e1. PubMed ID: 21723218
[TBL] [Abstract][Full Text] [Related]
11. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation.
Polkowski W; Baak JP; van Lanschot JJ; Meijer GA; Schuurmans LT; Ten Kate FJ; Obertop H; Offerhaus GJ
J Pathol; 1998 Feb; 184(2):161-8. PubMed ID: 9602707
[TBL] [Abstract][Full Text] [Related]
12. Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.
Kaye PV; Haider SA; Ilyas M; James PD; Soomro I; Faisal W; Catton J; Parsons SL; Ragunath K
Histopathology; 2009 May; 54(6):699-712. PubMed ID: 19438745
[TBL] [Abstract][Full Text] [Related]
13. Low-grade dysplasia in Barrett's esophagus has a high risk of progression.
Lim CH; Treanor D; Dixon MF; Axon AT
Endoscopy; 2007 Jul; 39(7):581-7. PubMed ID: 17611911
[TBL] [Abstract][Full Text] [Related]
14. [Barrett's oesophagus: endoscopic diagnosis and follow-up].
Ponsot P
Ann Chir; 2006 Jan; 131(1):3-6. PubMed ID: 16376849
[TBL] [Abstract][Full Text] [Related]
15. Routine morphometrical analysis can improve reproducibility of dysplasia grade in Barrett's oesophagus surveillance biopsies.
Baak JP; ten Kate FJ; Offerhaus GJ; van Lanschot JJ; Meijer GA
J Clin Pathol; 2002 Dec; 55(12):910-6. PubMed ID: 12461055
[TBL] [Abstract][Full Text] [Related]
16. [Reproducibility of histological criteria of dysplasia in Barrett mucosa].
Sagan C; Fléjou JF; Diebold MD; Potet F; Le Bodic MF
Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D31-4. PubMed ID: 8013780
[TBL] [Abstract][Full Text] [Related]
17. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variability in the diagnosis of crypt dysplasia in Barrett esophagus.
Coco DP; Goldblum JR; Hornick JL; Lauwers GY; Montgomery E; Srivastava A; Wang H; Odze RD
Am J Surg Pathol; 2011 Jan; 35(1):45-54. PubMed ID: 21164286
[TBL] [Abstract][Full Text] [Related]
19. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
[TBL] [Abstract][Full Text] [Related]
20. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
